Literature DB >> 12169859

The risk of obesity and the Trp64Arg polymorphism of the beta(3)-adrenergic receptor: effect modification by age.

M S Corbalán1, A Marti, L Forga, M A Martínez-Gonzalez, J A Martínez.   

Abstract

AIM: To examine the association between the risk of obesity and the Trp64Arg polymorphism of the beta(3)-adrenergic receptor gene.
METHODS: A case-control study was conducted. The case series encompassed 159 subjects with a body mass index >30 kg/m(2) (obesity) and no other major diseases except for type 2 diabetes, and the controls were 154 healthy subjects with a body mass index <25 kg/m(2). 313 Spanish subjects between 20 and 60 years of age were screened for the Trp64Arg mutation.
RESULTS: The prevalence of the Trp64Arg mutation was similar among cases (19.5%) and control subjects (16.2%). The association between the risk of obesity and the Trp64Arg mutation was estimated using multivariate logistic regression. A higher odds ratio of 3.84 (95% CI 1.33-11.12) for the mutation was found among younger individuals (20-35 years), while no increased risk was apparent among older participants (35-60 years). Moreover, when the model was adjusted for gender, age, and leisure-time physical activity, the product-term for interaction (effect modification) between age and the presence of the Trp64Arg mutation was statistically significant (likelihood ratio test p = 0.035).
CONCLUSION: Individuals aged 20-35 years who are Trp64Arg carriers had a substantially higher risk of developing obesity, independent of their sex or leisure-time physical activity. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169859     DOI: 10.1159/000063084

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  4 in total

1.  CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARgamma gene.

Authors:  A Marti; M S Corbalán; M A Martínez-González; L Forga; J A Martínez
Journal:  J Physiol Biochem       Date:  2002-12       Impact factor: 4.158

Review 2.  Candidate genes for type 2 diabetes.

Authors:  Hemang Parikh; Leif Groop
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Serotonin transporter gene promoter polymorphism is associated with body mass index and obesity in non-elderly stroke patients.

Authors:  M Y Lan; Y Y Chang; W H Chen; Y F Kao; H S Lin; J S Liu
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

4.  Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity.

Authors:  Amelia Marti; M Carmen Ochoa; Almudena Sánchez-Villegas; J Alfredo Martínez; Miguel Angel Martínez-González; Johannes Hebebrand; Anke Hinney; Helmut Vedder
Journal:  BMC Med Genet       Date:  2006-05-25       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.